Epigenetics of Myotonic Dystrophies: A Minireview.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Nov 2021
Historique:
received: 05 11 2021
revised: 19 11 2021
accepted: 20 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 17 12 2021
Statut: epublish

Résumé

Myotonic dystrophy type 1 and 2 (DM1 and DM2) are two multisystemic autosomal dominant disorders with clinical and genetic similarities. The prevailing paradigm for DMs is that they are mediated by an

Identifiants

pubmed: 34830473
pii: ijms222212594
doi: 10.3390/ijms222212594
pmc: PMC8623789
pii:
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Hum Mol Genet. 2010 Apr 15;19(8):1399-412
pubmed: 20080938
Nucleic Acids Res. 2016 May 5;44(8):3865-77
pubmed: 26921406
Exp Mol Med. 2015 Jun 05;47:e166
pubmed: 26045254
J Transl Med. 2010 May 20;8:48
pubmed: 20487562
Genes Dev. 2009 Apr 1;23(7):781-3
pubmed: 19339683
Biochem Soc Trans. 2009 Dec;37(Pt 6):1281-6
pubmed: 19909263
Am J Med Genet A. 2009 Jul;149A(7):1365-74
pubmed: 19514047
Am J Hum Genet. 2004 May;74(5):793-804
pubmed: 15065017
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):917-924
pubmed: 29291944
Acta Myol. 2020 Mar 01;39(1):13-18
pubmed: 32607474
Stem Cell Reports. 2015 Aug 11;5(2):221-31
pubmed: 26190529
Neurology. 2019 Sep 3;93(10):e995-e1009
pubmed: 31395669
Hum Mol Genet. 2019 Jul 1;28(13):2245-2254
pubmed: 31220271
PLoS One. 2015 Sep 04;10(9):e0137620
pubmed: 26339785
PLoS One. 2015 Apr 27;10(4):e0125341
pubmed: 25915631
Curr Opin Chem Biol. 2019 Aug;51:11-17
pubmed: 30825741
Curr Genomics. 2010 Apr;11(2):77-90
pubmed: 20885816
Front Neurol. 2018 Jun 19;9:463
pubmed: 29973908
Semin Neurol. 2011 Nov;31(5):470-83
pubmed: 22266885
Biochim Biophys Acta. 2015 Apr;1852(4):594-606
pubmed: 24882752
Am J Hum Genet. 2002 Oct;71(4):923-32
pubmed: 12232854
Front Genet. 2013 Jun 28;4:119
pubmed: 23825476
Curr Opin Genet Dev. 2003 Jun;13(3):246-52
pubmed: 12787786
Genes (Basel). 2020 Aug 13;11(8):
pubmed: 32823742
Trends Mol Med. 2013 Nov;19(11):655-63
pubmed: 23953480
Sci Adv. 2020 Jul 03;6(27):eaaz4012
pubmed: 32656337
PLoS One. 2012;7(6):e39732
pubmed: 22768114
Front Neurol. 2015 Dec 21;6:262
pubmed: 26733936
Dev Biol. 2016 Feb 1;410(1):1-13
pubmed: 26708096
Cell. 2018 Sep 20;175(1):224-238.e15
pubmed: 30173918
Neurobiol Dis. 2019 Dec;132:104533
pubmed: 31326502
Int J Endocrinol. 2015;2015:281756
pubmed: 26839547
Epigenomics. 2020 Dec;12(23):2051-2064
pubmed: 33301350
Cell Res. 2011 Mar;21(3):381-95
pubmed: 21321607
Nat Struct Mol Biol. 2010 Sep;17(9):1079-87
pubmed: 20711191
Sci Rep. 2016 Dec 01;6:38174
pubmed: 27905532
Hum Mol Genet. 2017 Sep 1;26(17):3285-3302
pubmed: 28637233
Front Genet. 2021 Jun 21;12:668094
pubmed: 34234810
Hum Mol Genet. 2001 Sep 15;10(19):2165-70
pubmed: 11590133
Neuromuscul Disord. 2014 Jun;24(6):509-15
pubmed: 24679513
Lancet Neurol. 2012 Oct;11(10):891-905
pubmed: 22995693
Hum Mol Genet. 2013 Feb 15;22(4):704-16
pubmed: 23139243
Neurol India. 2017 May-Jun;65(3):512-517
pubmed: 28488611
NAR Genom Bioinform. 2019 Jul 30;1(1):e3
pubmed: 33575550
Mol Cell. 2005 Nov 11;20(3):483-9
pubmed: 16285929
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Eur J Hum Genet. 2017 Feb;25(2):257-261
pubmed: 27876818
Epigenomics. 2016 Jan;8(1):13-31
pubmed: 26756355
Neurol Genet. 2020 Aug 12;6(5):e504
pubmed: 32851192
Hum Mol Genet. 2016 Sep 15;25(18):3960-3974
pubmed: 27466195
Nat Struct Mol Biol. 2011 Jun 19;18(7):840-5
pubmed: 21685920
Cell Rep. 2014 Jan 30;6(2):336-45
pubmed: 24412363
Neuromuscul Disord. 2011 Feb;21(2):81-8
pubmed: 21169019
J Clin Med. 2020 Dec 04;9(12):
pubmed: 33291833
Neurol Sci. 2017 Apr;38(4):619-625
pubmed: 28078570
Am J Hum Genet. 1998 Feb;62(2):278-85
pubmed: 9463318
Front Biosci (Landmark Ed). 2015 Jan 01;20:37-77
pubmed: 25553440
Am J Hum Genet. 2017 Mar 2;100(3):488-505
pubmed: 28257691
Hum Mol Genet. 2011 Jan 1;20(1):1-15
pubmed: 21044947
Trends Genet. 2009 Jul;25(7):288-97
pubmed: 19540013
Eur J Hum Genet. 2015 May;23(5):646-53
pubmed: 25052313
Science. 2001 Aug 3;293(5531):864-7
pubmed: 11486088
Mol Ther Methods Clin Dev. 2020 May 22;18:230-239
pubmed: 32637452
Front Neurol. 2018 May 02;9:303
pubmed: 29770119
Neurol Clin. 2014 Aug;32(3):705-19, viii
pubmed: 25037086
Mol Genet Metab. 2001 Sep-Oct;74(1-2):281-91
pubmed: 11592825
J Cell Mol Med. 2009 Jan;13(1):2-11
pubmed: 19175696
J Neuromuscul Dis. 2015 Jul 22;2(s2):S59-S71
pubmed: 27858759
Nat Genet. 2001 Aug;28(4):335-43
pubmed: 11479593
Neuroepidemiology. 2016;46(3):191-7
pubmed: 26882032
Neurology. 2009 Feb 10;72(6):490-7
pubmed: 19020295
Front Neurol. 2018 May 28;9:368
pubmed: 29892259
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):20-27
pubmed: 29193905
Epigenomics. 2020 Dec;12(23):2125-2139
pubmed: 33155830
Eur J Hum Genet. 2011 Jul;19(7):776-82
pubmed: 21364698
PLoS One. 2013 Dec 20;8(12):e83777
pubmed: 24376746
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Neurol Genet. 2019 May 23;5(3):e338
pubmed: 31334355
Neurol Sci. 2020 Oct;41(10):2953-2960
pubmed: 32350671
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5465-9
pubmed: 7777532
J Biol Chem. 1996 Jun 21;271(25):15222-9
pubmed: 8663027
J Nucleic Acids. 2013;2013:567435
pubmed: 24455202
Biochim Biophys Acta. 2015 Dec;1852(12):2645-52
pubmed: 26391753

Auteurs

Virginia Veronica Visconti (VV)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Federica Centofanti (F)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Simona Fittipaldi (S)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Elisa Macrì (E)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Giuseppe Novelli (G)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
IRCCS (Institute for Treatment and Research) Neuromed, 86077 Pozzilli, Italy.
Department of Pharmacology, School of Medicine, University of Nevada, Reno, NV 89557, USA.

Annalisa Botta (A)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH